Trial Profile
Assessing treatment options for smokers with asthma.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2016
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Beta-adrenergic receptor agonists
- Indications Asthma
- Focus Therapeutic Use
- 04 Jun 2013 Planned end date changed from 1 Jan 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.
- 10 Jan 2011 Planned end date changed from 1 Jan 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 10 Jun 2010 Planned end date changed from 1 Jan 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.